Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis
- 17 November 2022
- journal article
- research article
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (8) , 3725-3730
Abstract
The aim of this study was to investigate the risk factors for lymph node metastasis (LNM) in patients with uterine serous cancer (USC) who underwent systematic staging surgery. Eighty patients who were operated on for pure uterine serous papillary carcinoma between 2008 and 2020 in our clinic were retrospectively analysed. The effects of demographic information and clinicohistopathological characteristics of the included patients on LNM were examined. The median age of the patients included in the study was 64.3 and the tumour diameter was 3.8 cm. At the time of diagnosis, 65.8% of the cases were in the advanced stage, while 34.2% were in the early stage. There was no LNM in 42 (52.5%) of the cases, only pelvic in six (7.5%), only paraaortic LNM in four (5%) patients, and both pelvic and paraaortic LNM in 24 (30%) patients. When factors that may affect LNM were evaluated with multivariate analysis, lymphovascular space invasion (LVSI) and cytology positivity were found to be independent risk factors (p < 0.05). In addition, the rate of isolated paraaortic lymph node involvement in LNM positive patients is 5%, which is 100% associated with LVSI.Keywords
This publication has 38 references indexed in Scilit:
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- The Risk of Lymph Node Metastasis With Positive Peritoneal Cytology in Endometrial CancerInternational Journal of Gynecological Cancer, 2013
- Preoperative CA-125 predicts extra-uterine disease and survival in uterine papillary serous carcinoma patientsThe International Journal of Biological Markers, 2012
- Uterine papillary serous carcinoma: epidemiology, pathogenesis and managementCurrent Opinion in Obstetrics and Gynecology, 2010
- Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysisThe Lancet, 2009
- Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?Gynecologic Oncology, 2006
- ACOG Practice Bulletin #65: Management of Endometrial CancerObstetrics & Gynecology, 2005
- High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapyGynecologic Oncology, 2004
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983
- Uterine papillary serous carcinomaAmerican Journal of Surgical Pathology, 1982